Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Frontiers Production Office.
europepmc +1 more source
Classification and applicability of new beta-lactamase inhibitors. [PDF]
Cercenado E, Candel FJ.
europepmc +1 more source
Carbapenem resistance in a <i>Klebsiella quasipneumoniae</i> isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency. [PDF]
Findlay J +5 more
europepmc +1 more source
Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa. [PDF]
Le Terrier C +4 more
europepmc +1 more source
New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. [PDF]
Machado E, Sousa JC.
europepmc +1 more source
Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Sartori M, Toppo S, Lavezzo E.
europepmc +1 more source
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach. [PDF]
Tiseo G, Galfo V, Falcone M.
europepmc +1 more source
Mechanism, Dynamics and Inhibition of Class A β-Lactamases through Computation and Experiment [PDF]
Beer, Michael
core
Insights into antibiotic inactivation by β-lactamases from multiscale simulations [PDF]
Hirvonen, Viivi H A
core
Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]
Candel FJ, Matesanz M.
europepmc +1 more source

